These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11813938)

  • 1. Unsafe prescription medication switching recommendations.
    Subbiah P; Schwam EM
    Clin Ther; 2001 Dec; 23(12):2050-5. PubMed ID: 11813938
    [No Abstract]   [Full Text] [Related]  

  • 2. [[Donepezil : a new option in the treatment of Alzheimer's disease] ONEPA].
    Azanza JR; Sádaba B; Quetglas EG; Escolar M
    Rev Med Univ Navarra; 1998; 42(2):109-18. PubMed ID: 10420948
    [No Abstract]   [Full Text] [Related]  

  • 3. Featured CME topic: dementia. Medication update.
    Slagle MA
    South Med J; 2001 Jul; 94(7):678-81. PubMed ID: 11531174
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dementia of trisomy 21. Improvement with donepezil].
    Schill D
    Med Monatsschr Pharm; 2005 Oct; 28(10):371-2. PubMed ID: 16245462
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetic rationale for switching from donepezil to galantamine.
    Maelicke A
    Clin Ther; 2001; 23 Suppl A():A8-12. PubMed ID: 11396871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donepezil: a review.
    Seltzer B
    Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):527-36. PubMed ID: 16863459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donepezil and athetosis in an elderly patient with Alzheimer's disease.
    Tanaka M; Yokode M; Kita T; Matsubayashi K
    J Am Geriatr Soc; 2003 Jun; 51(6):889-90. PubMed ID: 12757588
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil and galantamine.
    Capellà D; Vidal X
    Age Ageing; 2007 Mar; 36(2):234; author reply 235. PubMed ID: 17255086
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis.
    Tan CC; Yu JT; Wang HF; Tan MS; Meng XF; Wang C; Jiang T; Zhu XC; Tan L
    J Alzheimers Dis; 2014; 41(2):615-31. PubMed ID: 24662102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic management of Alzheimer disease.
    Downey D
    J Neurosci Nurs; 2008 Feb; 40(1):55-9. PubMed ID: 18330411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Do medicines with aim to anti-Alzheimer favor the arisen of epileptic crisis? Discussion about 3 clinical cases].
    Roy M; Castro-Lionard K; Crawford-Achour E; Desseigne N; Beyens MN; Guy C; Imler D; Cornillon D
    Therapie; 2011; 66(3):291-3. PubMed ID: 23189344
    [No Abstract]   [Full Text] [Related]  

  • 12. Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine.
    Rodda J; Morgan S; Walker Z
    Int Psychogeriatr; 2009 Oct; 21(5):813-24. PubMed ID: 19538824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain injury, cognitive impairment, and donepezil.
    Whitlock JA
    J Head Trauma Rehabil; 1999 Aug; 14(4):424-7. PubMed ID: 10407214
    [No Abstract]   [Full Text] [Related]  

  • 14. Noncognitive symptoms and long-term treatment expectations for Alzheimer disease.
    Blesa R
    Alzheimer Dis Assoc Disord; 2004; 18 Suppl 1():S9-16. PubMed ID: 15249843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Galanthamine versus donepezil in the treatment of Alzheimer's disease].
    López-Pousa S; Garre-Olmo J; Vilalta-Franch J
    Rev Neurol; 2007 Jun 1-15; 44(11):677-84. PubMed ID: 17557224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donepezil-induced nightmares in mild cognitive impairment.
    Kitabayashi Y; Ueda H; Tsuchida H; Yamashita T; Narumoto J; Fukui K
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):123-4. PubMed ID: 16472374
    [No Abstract]   [Full Text] [Related]  

  • 17. Maintaining functional and behavioral abilities in Alzheimer disease.
    Winblad B
    Alzheimer Dis Assoc Disord; 2001 Aug; 15 Suppl 1():S34-40. PubMed ID: 11669508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic profiles of current therapies for Alzheimer's disease: implications for switching to galantamine.
    Farlow MR
    Clin Ther; 2001; 23 Suppl A():A13-24. PubMed ID: 11396867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How many patients complete an adequate trial of donepezil?
    Roe CM; Anderson MJ; Spivack B
    Alzheimer Dis Assoc Disord; 2002; 16(1):49-51. PubMed ID: 11882749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary incontinence: an unrecognised adverse effect with donepezil.
    Hashimoto M; Imamura T; Tanimukai S; Kazui H; Mori E
    Lancet; 2000 Aug; 356(9229):568. PubMed ID: 10950240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.